News
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...
The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...
Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...
Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.
A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top ...
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...
Moderna announced layoffs affecting 10% of its workforce amid government and competitive challenges to its vaccine business ...
You could be forgiven if you believed that the FDA granted full approval to Moderna's COVID-19 vaccines for children yesterday. Indeed, that's how many major media outlets portrayed things.
The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children ...
Moderna announced on Thursday that it had enrolled 30,000 participants in its Phase 3 COVID-19 vaccine trial, with more than 11,000 of those participants are from communities of color.
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease Written by moderna inc.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results